Kantoff, Philip W.
https://orcid.org/0000-0001-7275-0597
Mayo Clinic
39Convergent Therapeutics, Cambridge, MA
Citations 13
Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) and survival in metastatic prostate cancer (PCa).
Pomerantz, Mark M., Wang, Victoria , Lee, Gwo‐Shu Mary , Hahn, Noah M. , Jarrard, David F. , Liu, Glenn , García, Jorge A. , DiPaola, Robert S. , Freedman, Matthew L. , Kantoff, Philip W. , Xie, Wanling , Kohli, Manish , Wang, Elaine, Chen, Yu‐Hui , Carducci, Michael A. , Sweeney, Christopher J.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 1540-1540
Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression.
Armenia, Joshua , Yoshikawa, Yuki , Gerke, Travis , Komura, Kazumasa , Lee, Gwo‐Shu Mary , Mucci, Lorelei A. , Mazzu, Ying Zhang , Chakraborty, Goutam , Atiq, Mohammad Omar , Stopsack, Konrad H. , Kantoff, Philip W.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5044-5044
Symposium on Androgen Action in Prostate Cancer
Tindall, Donald J., Horne, Frances McFarland, Hruszkewycz, Andrew M., Mohla, Suresh, Shuman, Marc, Wang, Zhou , Kantoff, Philip W. , Kantoff, Philip W
Cancer Research | September 20, 2005 | Volume: 64 | Issue: 19 | Pages: 7178-7180